{"schema_version":"secwatch.filing_event.v1","accession":"0001699350-25-000015","form_type":"8-K","ticker":"SI","cik":"0001699350","company_name":"SHOULDER INNOVATIONS, INC.","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.180446+00:00","generated_at":"2026-05-16T21:19:13.062985+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Shoulder Innovations Q3 revenue up 58% to $11.8M; raises FY25 guidance to $45-46M","bullets":["Revenue $11.8M (+58% YoY); net loss $8.7M vs $4.1M loss in Q3 2024.","Gross margin 76.2%; sold 1,584 implant systems (+53% YoY).","Raises full-year 2025 revenue guidance to $45M-$46M from prior $42M-$44M.","Cash $137M after IPO and convertible notes; FDA clearance for fracture indications.","Adjusted EBITDA loss $7.5M vs $2.9M loss; SG&A $15.1M up 78% YoY on growth investments."],"urls":{"canonical":"https://secwatch.observer/filing/0001699350-25-000015","json":"https://secwatch.observer/filing/0001699350-25-000015.json","markdown":"https://secwatch.observer/filing/0001699350-25-000015.md","text":"https://secwatch.observer/filing/0001699350-25-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1699350/000169935025000015/0001699350-25-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1699350/000169935025000015/si-20251111.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T21:19:13.062985+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}